
Comparing Prednisone and Budesonide: Optimizing treatment in IgAN
In this medfyle
This retrospective study aimed to find out whether budesonide reduces mortality and ESRD compared to prednisone in IgAN. Results presented at Kidney Week 2024 suggest budesonide may be a superior alternative for long-term management.
About this Medfyle
©2024 Infomedica-Medfyle. All rights reserved.
Source: Optimizing IgAN Treatment: Comparing Prednisone and Budesonide Efficacy and Safety. Lohana A, et al. Presented at Kidney Week 2024; #FR-OR55.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.